| Target Price | $28.05 |
| Price | $11.32 |
| Potential |
147.79%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Novocure Ltd. 2026 .
The average Novocure Ltd. target price is $28.05.
This is
147.79%
register free of charge
$39.90
252.47%
register free of charge
$14.65
29.37%
register free of charge
|
|
| A rating was issued by 14 analysts: 10 Analysts recommend Novocure Ltd. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novocure Ltd. stock has an average upside potential 2026 of
147.79%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 605.22 | 662.93 |
| 18.82% | 9.54% | |
| EBITDA Margin | -25.98% | -8.76% |
| 40.36% | 66.29% | |
| Net Margin | -27.86% | -24.18% |
| 31.46% | 13.22% |
10 Analysts have issued a sales forecast Novocure Ltd. 2025 . The average Novocure Ltd. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Novocure Ltd. EBITDA forecast 2025. The average Novocure Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Novocure Ltd. Analysts have issued a net profit forecast 2025. The average Novocure Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.56 | -1.43 |
| 20.00% | 8.33% | |
| P/E | negative | |
| EV/Sales | 1.49 |
10 Analysts have issued a Novocure Ltd. forecast for earnings per share. The average Novocure Ltd. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 27 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Jul 08 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jun 27 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 27 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 25 2025 |
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Jul 08 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jun 27 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 23 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Apr 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


